Pharma Franchise in Neurology & Psychiatry Segment

Sr.No.	Brand Name	Dosage Form	Composition	Pack
1	Naprix D	Tablet	Naproxen 500 mg + Domperidone 10 mg	10*10 BLI
2	Citimeg 500	Liquid Injection	Citicoline 500 mg	2ml AMP.
3	Citimeg Plus	Tablet	Citicoline 500mg + Piracetam 800mg	10*10 Alu-Alu
4	Revelia 100	Syrup	Levetiracetam 100mg/ml	100 ml
5	Revelia 500	Tablet	Levetiracetam 500mg	10*10 BLI
6	Revelia	Injection	Levetiracetam 100 mg/ml	5 ml vial
7	Emgapin NT	Tablet	Gabapentin 400 mg + Nortriptyline 10 mg	10*15 Alu-Alu
8	Dizinel 10	Tablet	Flunarizine 10mg	10*10 Alu-Alu
9	Dizinel Plus	Capsule	Flunarizine HCI 10 mg +Propranolol HCI 40 mg	10*10 Alu-Alu
10	Nixoflex M	Tablet	Flupenthixol 0.5 MG+Melitracen 10 MG	10*10 Alu-Alu
11	Metlex	Capsule	Methylcobalamin 1500 mcg, Alpha Lipoic Acid 100mg , Pyridoxine 3mg, Folic Acid1.5mg (DRUG)	10*10 Alu-Alu
12	Metlex D3	Tablet	“Methylcobalamin 1500 Mcg, Alpha Lipoic Acid 100mg, Vitamin D3 1000 Iu , Pyridoxine 3mg,Folic Acid1.5mg “	10*10 Alu-Alu
13	Metlex Plus	Soft Gelatin Capsule	Methylcobalamin 1500 mcg+ Benfotiamine 150 mg + Alpha Lipoic Acid 100 mg + Inositol 100 mg + Folic Acid 1.5 mg + Chromium 200 mcg+ Selenium 55mcg (DRUG)	10*1*10
14	Regatol	Capsule	Pregabalin 75mg + Mecobalamin 750mcg	10*10 Alu-Alu
15	Regatol NT	Tablet	Pregabalin 75mg + Nortriptyline 10mg	10*10 Alu-Alu
16	Regatol NT Plus	Tablet	Pregabalin 75mg Sustained release + Nortriptyline 10mg + Methylcobalamin 1500 Mcg bilayered film coated	10*10 Alu-Alu
17	Regatol M SR 75	Tablet	Mecobalamin 1500mcg + Pregabalin 75mg Sustained Release	10*10 Alu-Alu
18	Vertikey 8	Tablet	Betahistine 8mg	10*10 Alu-Alu
19	Vertikey 16	Tablet	Betahistine 16mg	10*10 Alu-Alu

Pharma Franchise in Neuro Segment: Market Growth, Business Potential & Franchise Opportunities in India

The neuro pharmaceutical segment is rapidly emerging as one of the most specialized and high-value areas within the Indian healthcare industry. Rising cases of neurological disorders, increased diagnosis rates, and growing awareness of mental and neurological health have significantly boosted demand for neuro medicines across India.

As a result, investing in a pharma franchise in neuro segment has become an attractive opportunity for pharma distributors, medical representatives, and entrepreneurs seeking sustainable growth, premium margins, and long-term doctor loyalty.

This comprehensive guide explains the neuro pharma franchise model in India, market demand, product categories, regulatory considerations, profitability, future outlook, and how to choose the right neuro pharma franchise partner — backed by authoritative data and industry references

What Is a Pharma Franchise in Neuro Segment?

It refers to a business model where a pharmaceutical company grants distribution and marketing rights for neuro-related medicines to a franchise partner within a specific geographic area.

Under this model:

• The parent company manages manufacturing, quality control, and regulatory approvals
• The franchise partner handles local marketing, doctor engagement, and distribution
• Monopoly rights are usually provided

Neuro medicines are primarily prescribed by neurologists, psychiatrists, physicians, and super-specialists. Because treatment is often long-term, doctor trust and product consistency play a crucial role — making the neuro segment less price-driven and more quality-focused.

Neuro Pharmaceutical Market in India: Size & Growth

India is witnessing a steady rise in neurological and mental health disorders due to aging population, lifestyle changes, stress, and improved diagnosis rates.

According to the World Health Organization (WHO), neurological disorders are among the leading causes of disability worldwide, and low- and middle-income countries like India are experiencing a growing disease burden.

The Indian pharmaceutical industry is expected to reach USD 120–130 billion by 2030, as reported by India Brand Equity Foundation (IBEF). Neuro and CNS (central nervous system) drugs form a high-value therapeutic segment within this growth due to chronic usage and specialized treatment protocols.

Additionally, data from NIMHANS and WHO indicate increasing prevalence of conditions such as epilepsy, Parkinson’s disease, depression, anxiety disorders, and neuropathic pain in India.

Why the Neuro Segment Is Considered High-Value

Unlike acute therapy segments, neuro medicines are typically prescribed for long durations, sometimes lifelong.

Key characteristics of the neuro segment include:

• Chronic treatment cycles
• High doctor-brand loyalty
• Lower price sensitivity compared to general medicines
• Stable and predictable demand

Because patients rely heavily on physician guidance, doctors prefer prescribing brands with consistent quality and availability — which directly benefits reliable neuro pharma franchise partners.

Common Therapeutic Areas Covered in Neuro Pharma Franchise

A strong pharma franchise in neuro segment usually includes a wide range of CNS and neuro-related therapeutic categories:

1. Anti-Epileptic Drugs

• Used for seizure disorders
• Long-term and continuous therapy

2. Anti-Depressants & Anxiolytics

• SSRIs, SNRIs, and supportive neuro medicines
• Increasing demand due to mental health awareness

3. Neuropathic Pain Management

• Diabetic neuropathy
• Post-herpetic neuralgia

4. Anti-Parkinson’s Drugs

• Dopaminergic agents
• Adjunctive therapies

5. Neuro-Vitamins & Supplements

• Methylcobalamin combinations
• Nerve regeneration support

You can look at our list of products available for more information.

How the Neuro Pharma Franchise Model Works

Partnering with a pharma franchise in neuro segment generally involves:

1. Selection of a neuro-focused product portfolio
2. Allocation of exclusive territory rights
3. Provision of promotional tools (visual aids, LBLs, samples)
4. Continuous product supply
5. Ongoing marketing and business support

Because neuro marketing involves specialist doctors, scientific detailing and product knowledge are far more important than aggressive discounting.

Investment, Profit Margins & Business Potential

One of the biggest advantages of a pharma franchise in neuro segment is its profitability.

Typical business expectations include:

• Initial investment: Moderate to high (portfolio-dependent)
• Profit margins: 30%–60%
• Repeat orders: Very high due to chronic prescriptions
• Price erosion: Low compared to acute segments

Because patients often remain on therapy for extended periods, neuro franchises generate consistent secondary sales.

Pharma Franchise in Neuro Segment vs General Pharma Franchise

Factor	Neuro Pharma Franchise	General Pharma Franchise
Treatment duration	Long-term	Short-term
Doctor loyalty	Very high	Moderate
Price sensitivity	Low	High
Competition	Moderate	Very high
Profit stability	High	Variable

This comparison clearly highlights why many distributors prefer the pharma franchise in neuro segment for long-term growth

Common Myths About Neuro Pharma Franchise

Myth 1: Neuro medicines sell slowly
Reality: While patient onboarding may take time, repeat sales are extremely consistent.

Myth 2: Neuro franchise is only for big cities
Reality: Tier-2 and Tier-3 cities are witnessing rising neuro and mental health cases.

Myth 3: Neuro products are too complex to promote
Reality: With proper training and scientific support, promotion becomes easier over time.

How to Choose the Right Pharma Franchise in Neuro Segment

• Product Quality
• Portfolio Strength
• Monopoly Rights
• Marketing Support

At Kroyf Labs, we provide strong, consistent support to help our partners grow their business and improve sales. Our company culture is firmly rooted in quality at every level.

Future Outlook of Neuro Pharma Segment in India

India’s neuro pharma market is expected to grow steadily due to:

• Aging population
• Rising diabetes-related neuropathy
• Increasing mental health awareness
• Improved diagnostic capabilities

According to WHO and IBEF, chronic disease management and CNS therapies will remain key growth drivers within the pharmaceutical sector over the next decade.

The neuro segment’s reliance on long-term therapy positions it as one of the most future-ready pharma franchise opportunities in India.

Frequently Asked Questions (FAQs)